Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart

Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart

Source: 
BioSpace
snippet: 

Two months after Eli Lilly announced it would sell its authorized generic version of Humalog at a 50% lower list price, the discounted versions of the life-saving insulin have hit the streets.

On Wednesday, Indianapolis-based Eli Lilly announced that its Lispro Injection is available at pharmacies with the significantly lower list price. Lilly said the generic of Humalog is available in both a vial and KwikPen form.